Myra Robinson

5PUBLICATIONS
21CO-AUTHORS
Women's studies (incl. girls' studies)Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 25, 2025
Impact of Socioeconomic Factors on Surgical Approach and Outcomes in Young Women with Breast Cancer.

Jessica Bilz, Katie Bennett, Ferdous Ahmed

|Nov 22, 2024
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma.

Manisha Bhutani, Myra Robinson, David Foureau

|Mar 28, 2024
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study).

Hamid Ehsan, Myra Robinson, Peter M Voorhees

|Jun 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.

Thomas G Knight, Melissa Aguiar, Myra Robinson

|Sep 03, 2021
Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma.

Michael B Livingston, Megan H Jagosky, Myra M Robinson

Pageof 1

Frequent Collaborators

2 joint publications

David M Foureau

2 joint publications

Shebli Atrash

1 joint publications

Megan H Jagosky

1 joint publications

Jennifer H Benbow